What is Lucid Diagnostics's return on equity?

Lucid Diagnostics (LUCD) reported return on equity of -710.6% in Q4 2025.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Lucid Diagnostics LUCD Return on equity

Return on equity at other companies

Castle BiosciencesCSTL

-2.8%-10.6pp

Guardant HealthGH

-438.1%-1,655pp

Biodesix, Inc.BDSX

-316.5%—

Insight Molecular Diagnostics Inc. Common StockIMDX

-532.9%-717pp

Fulgent Genetics, Inc.FLGT

-6.8%+48.2pp

Personalis, Inc.PSNL

-41.4%-6.7pp

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Debt / equity0.4×—

Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

net income/total stockholders equity=-710.6%

Based on trailing twelve months.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's return on equity?: Lucid Diagnostics (LUCD) reported return on equity of -710.6% in Q4 2025.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.